NFE2L2 and gastric cancer: This increases the sensitivity to chemotherapy in gastric cancer cells, and offers a novel treatment strategy for advanced gastric cancer and chemotherapy resistance.192 Similarly, inhibiting Nrf2/Keap1/SLC7A11 pathway to promote ferroptosis in gastric cancer cells also increases the sensitivity of gastric cancer to cisplatin.193